Idexx Laboratories IDXX posted stronger-than-expected performance in the second quarter, and we've boosted our fair value estimate to reflect cash flows realized as well as more-optimistic estimates for the new acquisitions. Idexx saw solid 12% organic growth in the second quarter--in line with our ...
Among the companies that Morningstar analysts cover, these 15 are priced for perfection.
We've upgraded our moat ratings for Henry Schein and Patterson Companies to wide on distribution network cost advantages and high switching costs among their fragmented customers and suppliers.
The fund is more diversified than in years past, but no less focused on quality and the long term.
This venerable fund has made some changes to its portfolio, but it's still fabulous.
These keepers have closed before, so don't dawdle.
Who's in front heading 'round the bend?
These managers had more than just the wind at their backs.
While a majority of our top fund managers are outperforming this year, five of them truly stand out from the rest given their ability to outperform the market over all time periods.
Try this screen for core funds that take the road less travelled.